Saturday, April 25, 2026
33.6 C
Bengaluru

Pharma CEO Roundtable – Engaging Doctors – Physical, Digital and Hybrid: Translating Strategy into Action

The MedicinMan 10th Anniversary Special – Pharma CEO Roundtable 2021 Series 2 is Now Live

Pharma CEO Roundtable – Engaging Doctors – Physical, Digital and Hybrid: Translating Strategy into Action

Keynote Speaker: Dr. Mahender Nayak, Senior VP / Head of ICMEA* Region (India, Turkey, CIS Countries, Ukraine, Middle East & Africa) at Takeda.

Panel Members: Prakash Maheshwari, Vice President, Glenmark: Strategic Leadership | Pill+Service | Building Talent | Change Management | Risk-Taking & Innovation.

Sourabh Agrawal, Vice President – Sales & Marketing at Lupin Global.

Salil Kallianpur, Executive Editor of MedicinMan and former Executive VP – Emerging Markets at GSK.

Praful Akali, MD at Medulla Communications

– https://youtu.be/fYYdoXHBaW8 via YouTube

Hot this week

Is Pharma M&A Slowing Down Amidst Geopolitical Friction?

The pharmaceutical industry stands at a critical juncture in...

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

Topics

Is Pharma M&A Slowing Down Amidst Geopolitical Friction?

The pharmaceutical industry stands at a critical juncture in...

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...
spot_img

Related Articles

spot_imgspot_img